[ad_1] Google Cloud and the German health-care company Bayer on Tuesday announced they are building an artificial intelligence-powered platform that aims to help radiologists diagnose patients and work through cases more quickly. The platform’s generative AI flags anomalies within images for radiologists to look at, and it can also pull up relevant information from that…
[ad_1] Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021. Smith Collection | Gado | Getty Images Eli Lilly on Wednesday said Amazon Pharmacy will help send certain prescription drugs, including the red-hot weight loss treatment Zepbound, to patients’ homes through the drugmaker’s new direct-to-consumer program. Starting…
[ad_1] A closeup of Oura’s Gen3 Horizon ring and its sensors. Oura Oura will now sell its smart rings on Amazon, its latest retail expansion as the health and wellness wearable space continues to grow. Starting Thursday, Oura will have its full selection of rings and accessories available to U.S. shoppers on Amazon through its…
[ad_1] Salesforce headquarters in San Francisco, California, US, on Wednesday, Nov. 29, 2023. David Paul Morris | Bloomberg | Getty Images Salesforce on Thursday announced new data and artificial intelligence solutions for health-care workers that could help lessen their burdensome administrative workloads. The first tool is called Einstein Copilot: Health Actions, and it will allow…
[ad_1] Google Cloud CEO Thomas Kurian speaks at the Google Cloud Next event in San Francisco, April 9, 2019. Michael Short | Bloomberg | Getty Images Highmark Health announced Monday that it’s integrating technology from Google Cloud and the health-care software company Epic Systems to try to improve data gathering for providers and payers. Consumer…
[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks were mixed Tuesday, on a muted performance from Big Tech. Citigroup strategists warned that tech stocks may stall out after monstrous gains. “The large consensus positioning…
[ad_1] Traders work on the floor at the New York Stock Exchange on Feb. 1, 2024. Brendan McDermid | Reuters Here’s how big of a surprise corporate profits have been this earnings season: The fourth quarter is now shaping up to be the best of 2023. Despite ongoing macroeconomic concerns that have hampered demand and…
[ad_1] A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. George Frey | Reuters Norway’s giant wealth fund, the world’s largest, touted the possibility that Danish drugmaker Novo Nordisk and U.S. rival Eli…
[ad_1] We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful of company CEOs Jim interviewed at this week’s…
[ad_1] Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting. [ad_2] Source link
